Although pan-HDAC inhibitors like trichostatin A and sodium butyrate have shown effectiveness in reducing infarct size and enhancing functional recovery, the specific roles of individual HDACs in ischemia remain controversial [237]. The gene discussed is HDAC9; the disease is ischemia.